Low Dose Priming with Methyl-CCNU Reduces Toxicity and Increases Lifespan in Mice
Author Information
Author(s): A. Zimber, K. Perk, I. Livnat
Primary Institution: Department of Animal Science and Koret School of Veterinary Medicine, Faculty of Agriculture, P.O. Box 12, Rehovot 76100, Israel
Hypothesis
Can low doses of methyl-CCNU reduce the toxicity of high doses and increase the lifespan of mice with cancer?
Conclusion
Priming with low doses of methyl-CCNU significantly reduces toxicity and increases the lifespan of mice treated with high doses.
Supporting Evidence
- Low doses of methyl-CCNU reduced mortality rates in mice treated with lethal doses.
- Body weight and organ weights were better in mice pretreated with low doses.
- Priming with low doses did not protect the tumor but reduced toxicity to normal tissues.
Takeaway
Giving mice a little bit of a medicine before a big dose helps them feel better and live longer.
Methodology
Inbred male C57B1 mice were treated with low and high doses of methyl-CCNU and melphalan, and their survival and organ weights were measured.
Potential Biases
Potential bias in treatment administration and measurement of outcomes.
Limitations
The study was conducted on mice, and results may not directly translate to humans.
Participant Demographics
Inbred male C57B1 mice.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website